Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TRAZODONE D TABLETS 150MG | 150MG | TABLET | Resolved | 2024-01-05 | 2024-03-01 | 215224 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-01-05 | 2024-03-08 | 215227 |
APO PREDNISONE TAB 50MG | 50MG | TABLET | Resolved | 2024-01-05 | 2024-01-12 | 215230 |
APO-METOPROLOL | 25MG | TABLET | Resolved | 2024-01-05 | 2024-03-22 | 215233 |
TRI-CIRA 21 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | TABLET | Resolved | 2024-01-05 | 2024-02-02 | 215236 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2024-01-05 | 2024-03-08 | 215239 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2024-01-05 | 2024-01-26 | 215242 |
APO-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-01-12 | 2024-03-01 | 215964 |
APO-IBUPROFEN TAB 600MG | 600MG | TABLET | Resolved | 2024-01-12 | 2024-03-29 | 215967 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2024-01-12 | 2024-03-15 | 215970 |
APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-12 | 2024-03-22 | 215973 |
APO-SOTALOL | 160MG | TABLET | Resolved | 2024-01-12 | 2024-01-19 | 215976 |
APO-ROSUVASTATIN | 10MG | TABLET | Resolved | 2024-01-12 | 2024-02-09 | 215979 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-01-19 | 2024-03-22 | 216653 |
APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2024-01-19 | 2024-02-23 | 216656 |
APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2024-01-19 | 2024-02-09 | 216659 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-19 | 2024-02-09 | 216662 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2024-01-19 | 2024-05-22 | 216669 |
APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2024-01-19 | 2024-02-09 | 216672 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |